Skip to main content
Log in

Prognostic value of deep learning–based fibrosis quantification on chest CT in idiopathic pulmonary fibrosis

  • Chest
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objective

To investigate the prognostic value of deep learning (DL)–driven CT fibrosis quantification in idiopathic pulmonary fibrosis (IPF).

Methods

Patients diagnosed with IPF who underwent nonenhanced chest CT and spirometry between 2005 and 2009 were retrospectively collected. Proportions of normal (CT-Norm%) and fibrotic lung volume (CT-Fib%) were calculated on CT using the DL software. The correlations of CT-Norm% and CT-Fib% with forced vital capacity (FVC) and diffusion capacity of carbon monoxide (DLCO) were evaluated. The multivariable-adjusted hazard ratios (HRs) of CT-Norm% and CT-Fib% for overall survival were calculated with clinical and physiologic variables as covariates using Cox regression. The feasibility of substituting CT-Norm% for DLCO in the GAP index was investigated using time-dependent areas under the receiver operating characteristic curve (TD-AUCs) at 3 years.

Results

In total, 161 patients (median age [IQR], 68 [62–73] years; 104 men) were evaluated. CT-Norm% and CT-Fib% showed significant correlations with FVC (Pearson’s r, 0.40 for CT-Norm% and − 0.37 for CT-Fib%; both p < 0.001) and DLCO (0.52 for CT-Norm% and − 0.46 for CT-Fib%; both p < 0.001). On multivariable Cox regression, both CT-Norm% and CT-Fib% were independent prognostic factors when adjusted to age, sex, smoking status, comorbid chronic diseases, FVC, and DLCO (HRs, 0.98 [95% CI 0.97–0.99; p < 0.001] for CT-Norm% at 3 years and 1.03 [1.01–1.05; p = 0.01] for CT-Fib%). Substituting CT-Norm% for DLCO showed comparable discrimination to the original GAP index (TD-AUC, 0.82 [0.78–0.85] vs. 0.82 [0.79–0.86]; p = 0.75).

Conclusion

CT-Norm% and CT-Fib% calculated using chest CT–based deep learning software were independent prognostic factors for overall survival in IPF.

Key Points

• Normal and fibrotic lung volume proportions were automatically calculated using commercial deep learning software from chest CT taken from 161 patients diagnosed with idiopathic pulmonary fibrosis.

• CT-quantified volumetric parameters from commercial deep learning software were correlated with forced vital capacity (Pearson’s r, 0.40 for normal and − 0.37 for fibrotic lung volume proportions) and diffusion capacity of carbon monoxide (Pearson’s r, 0.52 and − 0.46, respectively).

• Normal and fibrotic lung volume proportions (hazard ratios, 0.98 and 1.04; both p < 0.001) independently predicted overall survival when adjusted for clinical and physiologic variables.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

ATS/ERS/JRS/ALAT:

American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin American Thoracic Association

CT-Fib%:

Fibrotic lung volume proportion

CT-Norm%:

Normal lung volume proportion

DLCO :

Diffusion capacity of carbon monoxide

DLCO%:

Diffusion capacity of carbon monoxide, expressed as a percentage of the predicted value

FEV1%:

Forced expiratory volume in 1 s, expressed as a percentage of the predicted value

FVC:

Forced vital capacity

FVC%:

Forced vital capacity, expressed as a percentage of the predicted value

GAP:

Gender, age, and physiology

IPF:

Idiopathic pulmonary fibrosis

References

  1. Lederer DJ, Martinez FJ (2018) Idiopathic pulmonary fibrosis. N Engl J Med 378:1811–1823

    Article  CAS  PubMed  Google Scholar 

  2. Raghu G, Chen S-Y, Yeh W-S et al (2014) Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11. Lancet Respir Med 2:566–572

    Article  PubMed  Google Scholar 

  3. Richeldi L, Du Bois RM, Raghu G et al (2014) Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370:2071–2082

    Article  PubMed  Google Scholar 

  4. King TE Jr, Bradford WZ, Castro-Bernardini S et al (2014) A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 370:2083–2092

    Article  PubMed  Google Scholar 

  5. Khor YH, Ng Y, Barnes H, Goh NS, McDonald CF (2020) Holland AE (2020) Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review. Eur Respir Rev 29(157):190158

    Article  PubMed  PubMed Central  Google Scholar 

  6. Raghu G, Collard HR, Egan JJ et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824

    Article  PubMed  PubMed Central  Google Scholar 

  7. National Institue for Health and Care Excellence: Idiopathic pulmonary fibrosis in adults: diagnosis and management. Available online: https://www.nice.org.uk/guidance/cg163. Accessed May 4, 2022

  8. Raghu G, Remy-Jardin M, Myers JL et al (2018) Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 198:e44–e68

    Article  PubMed  Google Scholar 

  9. Lynch DA, Sverzellati N, Travis WD et al (2018) Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med 6:138–153

    Article  PubMed  Google Scholar 

  10. Ley B, Elicker BM, Hartman TE et al (2014) Idiopathic pulmonary fibrosis: CT and risk of death. Radiology 273:570–579

    Article  PubMed  Google Scholar 

  11. Ley B, Ryerson CJ, Vittinghoff E et al (2012) A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med 156:684–691

    Article  PubMed  Google Scholar 

  12. Kim ES, Choi SM, Lee J et al (2015) Validation of the GAP score in Korean patients with idiopathic pulmonary fibrosis. Chest 147:430–437

    Article  PubMed  Google Scholar 

  13. Kim H, Jin KN, Yoo S-J et al (2022) Deep learning for estimating lung capacity on chest radiographs predicts survival in idiopathic pulmonary fibrosis. Radiology 306(3):e220292. https://doi.org/10.1148/radiol.220292

  14. Graham BL, Steenbruggen I, Miller MR et al (2019) Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement. Am J Respir Crit Care Med 200:e70–e88

    Article  PubMed  PubMed Central  Google Scholar 

  15. Kang MJ, Won Y-J, Lee JJ et al (2022) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2019. Cancer Res Treat 54:330–344

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kim MS, Choe J, Hwang HJ et al (2022) Interstitial lung abnormalities (ILA) on routine chest CT: comparison of radiologists’ visual evaluation and automated quantification. Eur J Radiol 157:110564

    Article  PubMed  Google Scholar 

  17. Kim GB, Jung K-H, Lee Y et al (2018) Comparison of shallow and deep learning methods on classifying the regional pattern of diffuse lung disease. J Digit Imaging 31:415–424

    Article  PubMed  Google Scholar 

  18. Park B, Park H, Lee SM, Seo JB, Kim N (2019) Lung segmentation on HRCT and volumetric CT for diffuse interstitial lung disease using deep convolutional neural networks. J Digit Imaging 32:1019–1026

    Article  PubMed  PubMed Central  Google Scholar 

  19. Blanche P, Dartigues JF, Jacqmin-Gadda H (2013) Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med 32:5381–5397

    Article  PubMed  Google Scholar 

  20. Lynch DA, Godwin JD, Safrin S et al (2005) High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 172:488–493

    Article  PubMed  Google Scholar 

  21. Best AC, Meng J, Lynch AM et al (2008) Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality. Radiology 246:935–940

    Article  PubMed  Google Scholar 

  22. Macintyre N, Crapo R, Viegi G et al (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26:720–735

    Article  CAS  PubMed  Google Scholar 

  23. Desjardin A, Creveuil C, Bergot E, Normand H (2020) Assessment of concordance between diffusion of carbon monoxide through the lung using the 10 s breath-hold method, and the simultaneous NO/CO technique, in healthy participants. Respir Physiol Neurobiol 273:103319

    Article  CAS  PubMed  Google Scholar 

  24. Capaccione KM, Wang A, Lee SM et al (2021) Quantifying normal lung in pulmonary fibrosis: CT analysis and correlation with% DLCO. Clin Imaging 77:287–290

    Article  PubMed  Google Scholar 

  25. Calandriello L, Walsh SL (2022) The evolution of computer-based analysis of high-resolution CT of the chest in patients with IPF. Br J Radiol 95(1132):20200944

    Article  PubMed  Google Scholar 

  26. Aziz ZA, Wells AU, Hansell DM et al (2004) HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation. Thorax 59:506–511

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Ash SY, Harmouche R, Vallejo DLL et al (2017) Densitometric and local histogram based analysis of computed tomography images in patients with idiopathic pulmonary fibrosis. Respir Res 18:1–11

    Article  Google Scholar 

  28. Loeh B, Brylski LT, von der Beck D et al (2019) Lung CT densitometry in idiopathic pulmonary fibrosis for the prediction of natural course, severity, and mortality. Chest 155:972–981

    Article  PubMed  Google Scholar 

  29. Kim HJ, Brown MS, Chong D et al (2015) Comparison of the quantitative CT imaging biomarkers of idiopathic pulmonary fibrosis at baseline and early change with an interval of 7 months. Acad Radiol 22:70–80

    Article  PubMed  Google Scholar 

  30. Siddique N, Paheding S, Elkin CP, Devabhaktuni V (2021) U-net and its variants for medical image segmentation: a review of theory and applications. IEEE Access 9:82031–82057

    Article  Google Scholar 

  31. Humphries SM, Swigris JJ, Brown KK et al (2018) Quantitative high-resolution computed tomography fibrosis score: performance characteristics in idiopathic pulmonary fibrosis. Eur Resp J 52(3):1801384

    Article  Google Scholar 

  32. Humphries SM, Mackintosh JA, Jo HE et al (2022) Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis. Respirology 27:1045–1053. https://doi.org/10.1111/resp.14333

  33. Handa T, Tanizawa K, Oguma T et al (2022) Novel artificial intelligence-based technology for chest computed tomography analysis of idiopathic pulmonary fibrosis. Ann Am Thorac Soc 19:399–406

    Article  PubMed  Google Scholar 

  34. Ley B, Collard HR, King TE Jr (2011) Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 183:431–440

    Article  PubMed  Google Scholar 

  35. Lamas DJ, Kawut SM, Bagiella E, Philip N, Arcasoy SM, Lederer DJ (2011) Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study. Am J Respir Crit Care Med 184(7):842–847

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study has received funding by the Research Program 2020 funded by Seoul National University College of Medicine Research Foundation (800-20200313), the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2020R1C1C1003684), and the grant from the Seoul National University Hospital Research Fund (04-2020-2040). However, the funders had no role in the study design; in the collection, analysis, and interpretation of the data; in the writing of the report; and in the decision to submit the article for publication.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hyungjin Kim.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Hyungjin Kim.

Conflict of interest

Author Hyungjin Kim is a member of European Radiology Scientific Editorial board. He has not taken part in review or selection process for this manuscript. The remaining authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

Statistics and biometry

Statistical analyses were performed by a statistician with 15 years of experience (Yunhee Choi). She is one of the co-authors.

Informed consent

Written informed consent was waived by the Institutional Review Board.

Ethical approval

Institutional Review Board approval was obtained.

Study subjects or cohorts overlap

The patients in our study have been reported in previous publications on validation of the GAP score and lung volume estimation using chest radiographs.

Kim ES, Choi SM, Lee J, et al Validation of the GAP score in Korean patients with idiopathic pulmonary fibrosis. Chest. 2015;147(2):430–437. https://doi.org/10.1378/chest.14-0453; and in submitted: Deep Learning for Estimating Lung Capacity on Chest Radiographs to Predict Survival in Idiopathic Pulmonary Fibrosis as PDF in file inventory.

Methodology

  • retrospective

  • observational

  • performed at one institution

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 644 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nam, J.G., Choi, Y., Lee, SM. et al. Prognostic value of deep learning–based fibrosis quantification on chest CT in idiopathic pulmonary fibrosis. Eur Radiol 33, 3144–3155 (2023). https://doi.org/10.1007/s00330-023-09534-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-023-09534-y

Keywords

Navigation